Table 4.
Pathogens responsible for HAIs isolated in microbiological studies, and clinical forms of HAIs in neurosurgery in the years 2014–2019.
| Pathogen Type | Clinical Forms of HAIs | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| BSI | PN | UTI | SSI | Total | |||||
| Hospital A | Hospital B | Hospital A | Hospital B | Hospital A | Hospital B | Hospital A | Hospital B | ||
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
| Gram-positive cocci n (%) | 14 (41.2) | 14 (60.9) | 8 (13.3) | 4 (7.7) | 2 (9.5) | 16 (18.4) | 41(53.2) | 5 (26.3) | 104 (28.0) |
| Staphylococcus aureus | 5 (14.7) | 7 (30.5) | 6 (10.0) | 1 (1.9) | 1 (4.8) | 0 (0.0) | 20 (26.0) | 3 (15.8) | 43 (11.5) |
| Staphylococcus epidermidis | 4 (11.8) | 6 (26.1) | 0 (0.0) | 1 (1.9) | 0 (0.0) | 1 (1.1) | 12 (15.6) | 2 (10.5) | 26 (7.0) |
| Other Gram-positive | 5 (14.7) | 1 (4.3) | 2 (3.3) | 2 (3.8) | 1 (4.8) | 15 (17.2) | 9 (11.7) | 0 (0.0) | 35 (9.4) |
| Enterobacteriaceae n (%) | 12 (35.3) | 6 (26,1) | 15 (25.0) | 6 (11,5) | 11 (52.4) | 44 (50.6) | 14 (18,2) | 10 (52.7) | 118 (31.6) |
| Klebsiella pneumoniae | 3 (8.8) | 2 (8.7) | 6 (10.0) | 2 (3.8) | 4 (19.0) | 18 (20.7) | 5 (6.5) | 5 (26.3) | 45 (12.0) |
| Escherichia coli | 3 (8.8) | 1 (4.3) | 3 (5.0) | 2 (3.8) | 6 (28.6) | 23 (26.4) | 2 (2.6) | 2 (10.5) | 42 (11.3) |
| Enterobacter cloacae | 5 (14.7) | 1 (4.3) | 3 (5.0) | 1 (1.9) | 1 (4.8) | 2 (2.3) | 5(6.5) | 0 (0.0) | 18 (4.8) |
| Other Enterobacteriaceae | 1 (2.9) | 2 (8.7) | 3 (5.0) | 1 (1.9) | 0 (0.0) | 1 (1.1) | 2 (2.6) | 3 (15.8) | 13 (3.5) |
| Non-fermenting Gram-negative bacteria n (%) | 6 (17.6) | 2 (8.7) | 13 (21.7) | 1 (1.9) | 4 (19.0) | 5 (5.7) | 17 (22.1) | 0 (0,0) | 48 (12.9) |
| Pseudomonas aeruginosa | 1 (2.9) | 1 (4.3) | 0 (0.0) | 0 (0.0) | 3 (14.3) | 3 (3.4) | 7 (9.1) | 0 (0.0) | 15 (4.0) |
| Acinetobacter baumannii | 5 (14.7) | 1 (4.3) | 13 (21.7) | 1 (1.9) | 1 (4.8) | 2 (2.3) | 10 (13.0) | 0 (0.0) | 33 (8.8) |
| Other n (%) | 2 (5.9) | 0 (0.0) | 1 (1.7) | 0 (0.0) | 4 (19.0) | 3 (3.4) | 0 (0.0) | 0 (0.0) | 10 (2.7) |
| Candida spp. | 2 (5.9) | 0 (0.0) | 1 (1.7) | 0 (0.0) | 4 (19.0) | 3 (3.4) | 0 (0.0) | 0 (0.0) | 10 (2.7) |
| No microbiological confirmation n (%) | 0 (0.0) | 1 (4.3) | 23 (38.3) | 41 (78.9) | 0 (0.0) | 19 (21.8) | 5 (6.5) | 4 (21.0) | 93 (24.9) |
| NO TEST | 0 (0.0) | 1 (4.3) | 17 (28.3) | 41 (78.9) | 0 (0.0) | 18 (20.7) | 4 (5.2) | 4 (21.0) | 85 (22.8) |
| NO GROWTH * | 0 (0.0) | 0 (0.0) | 6 (10.0) | 0 (0.0) | 0 (0.0) | 1 (1.1) | 1 (1.3) | 0 (0.0) | 8 (2.1) |
| Total n (%) | 34 (100) | 23 (100) | 60 (100) | 52 (100) | 21 (100) | 87 (100) | 77 (100) | 19 (100) | 373 (100) |
Healthcare-associated infections (HAI), Clostridioides difficile Infection (CDI)-13 cases; skin and soft tissue (9 cases), number (n), percentage (%), bloodstream infection (BSI), pneumonia (PN), surgical site infection (SSI), urinary tract infection (UTI), * no microorganisms were detected in the collected material.